Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06310837Not ApplicableActive Not Recruiting

Effect of Immunosuppressants With Adalimumab Biosimilars vs Corticosteroids on Noninfectious Uveitis

Role: collaborator

NCT05628909Not ApplicableUnknown

Silicone Oil Tamponade for Vitrectomy of Hypermyopic Foveoschisis.

Role: collaborator

NCT03229239Not ApplicableUnknown

Corneal Stroma Implantation for the Treatment of Keratoconus

Role: lead

NCT02911532Not ApplicableUnknown

Tissue Engineering Conjunctiva for the Treatment of Pterygium and Atretoblepharia

Role: lead

All 4 trials loaded